Stewart Pierson, DPM
Podiatrist · Bessemer, ALNPI 1255749107
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,593 of the $2,047 with a category attached, or 77.8%. 15 manufacturers reported payments, led by Musculoskeletal Transplant Foundation Inc. at 40.3% of the total. Reporting peaked in 2019 at $1,083 and has fallen 79.9% since, to $217 in 2025.
Across 56 payments — averaging $36.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$824
- Organogenesis Inc.$644
- Amgen$329
- Stryker$73
- Smith+Nephew$33
- Abbott$18
- plus $125 from 9 others
What the payments were for
- Speaking & faculty fees$603%
- Travel & lodging$39319%
- Food & beverage$1,59378%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 10 | $824 |
| Organogenesis Inc. | 28 | $644 |
| Amgen(2 entities) | 4 | $329 |
| Stryker | 2 | $73 |
| Smith+Nephew | 2 | $33 |
| Abbott | 1 | $18 |
| Melinta Therapeutics, LLC | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Paragon 28, Inc. | 1 | $15 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Merck | 1 | $13 |
| KCI USA, Inc. | 1 | $12 |
| Orthofix Medical, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KRYSTEXXA$223
How this compares
$2,047 in reported general payments places this provider in the 70th percentile of 59 podiatrist providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 29 | $783 |
| Naproxen | 72 | $715 |
| Methylprednisolone | 53 | $523 |
| Cephalexin | 60 | $381 |
| Doxycycline Monohydrate | 24 | $376 |
| Terbinafine Hcl | 29 | $278 |
| Clotrimazole | 12 | $135 |
| Mupirocin | 17 | $107 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $76 |
| Triamcinolone Acetonide | 13 | $69 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Bessemer
- Shane BurchfieldBessemer$232
- Stephen SternBessemer$174
- Michael HamesFlorence$100K
- James MorganMobile$21K
- John RobersonBirmingham$10K
- Kyle MaukBirmingham$10K
- Johnnie AlstonMontgomery$9K
- Heidi ChristieMontgomery$7K
- Brent HaverstockBirmingham$7K
- David LindeBirmingham$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.